SYNTHOMER LS -,01/ GB00BNTVWJ75 /
2024-06-24 9:33:03 AM | Chg. -0.065 | Volume | Bid9:51:40 AM | Ask9:51:40 AM | High | Low |
---|---|---|---|---|---|---|
3.000EUR | -2.12% | 0 Turnover: 0.000 |
2.950Bid Size: 6,750 | 3.050Ask Size: 6,750 | 3.065 | 2.970 |
GlobeNewswire
10:00 AM
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
GlobeNewswire
10:00 AM
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00 AM
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
9:53 AM
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Cla...
GlobeNewswire
9:00 AM
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39 AM
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00 AM
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30 AM
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30 AM
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...